Page 53 - ESGO - Vulvar cancer - Complete report_fxd2

38. AHS. Squamous Cell Carcinoma of the
Vulva.
http://www.albertahealthservices.ca/hp/if-
hp-cancer-guide-gyne006-vulva.pdf
(2013).
39. NCCN. Vulvar Cancer (Squamous Cell
Carcinoma). Version 1.
http://www.nccn.org/professionals/physici
an_gls/f_guidelines.asp (2016).
40. Farias-Eisner, R., et al. Conservative and
individualized surgery for early squamous
carcinoma of the vulva: the treatment of
choice for stage I and II (T1-2N0-1M0)
disease. Gynecol Oncol 53, 55-58 (1994).
41. Balat, O., Edwards, C. & Delclos, L.
Complications following combined
surgery (radical vulvectomy versus wide
local excision) and radiotherapy for the
treatment of carcinoma of the vulva: report
of 73 patients. Eur J Gynaecol Oncol 21,
501-503 (2000).
42. De Hullu, J.A., et al. Vulvar carcinoma.
The price of less radical surgery. Cancer
95, 2331-2338 (2002).
43. Rutledge, F.N., et al. Prognostic indicators
for invasive carcinoma of the vulva.
Gynecol Oncol 42, 239-244 (1991).
44. DeSimone, C.P., et al. The treatment of
lateral T1 and T2 squamous cell
carcinomas of the vulva confined to the
labium majus or minus. Gynecol Oncol
104, 390-395 (2007).
45. van der Velden, J. Surgical interventions
for early squamous cell carcinoma of the
vulva. Cochrane Database Syst Rev,
CD002036 (2000).
46. Burke, T.W., et al. Surgical therapy of T1
and T2 vulvar carcinoma: further
experience with radical wide excision and
selective inguinal lymphadenectomy.
Gynecol Oncol 57, 215-220 (1995).
47. DiSaia, P.J., Creasman, W.T. & Rich,
W.M. An alternate approach to early
cancer of the vulva. Am J Obstet Gynecol
133, 825-832 (1979).
 VULVAR CANCER - GUIDELINES 
48. Heaps, J.M., Fu, Y.S., Montz, F.J., Hacker,
N.F. & Berek, J.S. Surgical-pathologic
variables predictive of local recurrence in
squamous cell carcinoma of the vulva.
Gynecol Oncol 38, 309-314 (1990).
49. Tantipalakorn, C., Robertson, G.,
Marsden, D.E., Gebski, V. & Hacker, N.F.
Outcome and patterns of recurrence for
International Federation of Gynecology
and Obstetrics (FIGO) stages I and II
squamous cell vulvar cancer. Obstet
Gynecol 113, 895-901 (2009).
50. Berman, M.L., Soper, J.T., Creasman,
W.T., Olt, G.T. & DiSaia, P.J.
Conservative surgical management of
superficially invasive stage I vulvar
carcinoma. Gynecol Oncol 35, 352-357
(1989).
51. Gunther, V., et al. Impact of radical
operative treatment on the quality of life in
women with vulvar cancer--a retrospective
study. Eur J Surg Oncol 40, 875-882
(2014).
52. Curry, S.L., Wharton, J.T. & Rutledge, F.
Positive lymph nodes in vulvar squamous
carcinoma. Gynecol Oncol 9, 63-67
(1980).
53. Hacker, N.F., Berek, J.S., Lagasse, L.D.,
Leuchter, R.S. & Moore, J.G. Management
of regional lymph nodes and their
prognostic influence in vulvar cancer.
Obstet Gynecol 61, 408-412 (1983).
54. Hacker, N.F., Berek, J.S., Lagasse, L.D.,
Nieberg, R.K. & Leuchter, R.S.
Individualization of treatment for stage I
squamous cell vulvar carcinoma. Obstet
Gynecol 63, 155-162 (1984).
55. Hoffman, J.S., Kumar, N.B. & Morley,
G.W. Microinvasive squamous carcinoma
of the vulva: search for a definition. Obstet
Gynecol 61, 615-618 (1983).
56. Ross, M.J. & Ehrmann, R.L. Histologic
prognosticators in stage I squamous cell
carcinoma of the vulva. Obstet Gynecol
70, 774-784 (1987).
53